It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2011.
2011 | Mumbai, Maharashtra, India | ActiveA-Mark Pharma Private Limited, a active private limited company, was established on 17 February 2011 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24233MH2011PTC213660. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Suresh Chand Mandhana (Director), Shilpi Mandhana (Director). Past directors included Suresh Chand Mandhana, Rohitash Kailashchand Mandhana. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 411 Atlanta Estate Premises Co-Op. Society Limited G. M. Link Road, Near Virwani, Goregaon, (East), Mumbai, Maharashtra, 400063.
U24233MH2011PTC213660
213660
17 February 2011
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into A-Mark Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suresh Chand Mandhana | Director | 25 Jan 2022 | Current |
| Shilpi Mandhana | Director | 17 Feb 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 11 Mar 2023 | Past |
| Pramod Abcsdd | Director | 25 Jan 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
A-Mark Pharma Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 80.16% increase in profit. The company's net worth dipped by a decrease of 2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, A-Mark Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with A-Mark Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of A-Mark Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A-Mark Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A-Mark Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A-Mark Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on Suresh Chand Mandhana was appointed as a Director was appointed as a Director on 25 Jan 2022 & has been associated with this company since 3 years 10 months . was documented.
Progress on Shilpi Mandhana was appointed as a Director was appointed as a Director on 17 Feb 2011 & has been associated with this company since 14 years 9 months . was documented.
Progress on A-Mark Pharma Private Limited was registered on 17 Feb 2011 with Roc Mumbai & aged 14 years 9 months as per MCA records. was documented.
The CIN of A-Mark Pharma Private Limited is U24233MH2011PTC213660.
A-Mark Pharma Private Limited is headquartered at 411 Atlanta Estate Premises Co-Op. Society Limited G. M. Link Road, Near Virwani, Goregaon, (East), Mumbai, Maharashtra, 400063.
A-Mark Pharma Private Limited was incorporated on 17 February 2011.
The current directors of A-Mark Pharma Private Limited are
The primary industry of A-Mark Pharma Private Limited is Manufacturing.
A-Mark Pharma Private Limited is unlisted.
The authorized capital of A-Mark Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of A-Mark Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX